AstraZeneca (AZN) Earnings Date and Reports 2024 (2024)

Earnings Summary

Upcoming
Earnings Date
Jul. 26Estimated

Actual EPS
(Apr. 25)
$1.03 Beat By $0.08

Consensus EPS
(Apr. 25)
$0.95

Get AstraZeneca Earnings Alerts

Enter your email address below to receive the latest news and earnings results for AZN and its competitors with MarketBeat's FREE daily newsletter.

Earnings Per ShareRevenue

AZN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

AZN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products.If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE…The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now.

AstraZeneca Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242$0.87$0.95$0.91
Q2 20242$0.91$1.03$0.97
Q3 20242$0.99$1.07$1.03
Q4 20242$1.07$1.08$1.08
FY 20248$3.84$4.13$3.99
Q1 20251$1.05$1.05$1.05
Q2 20251$1.11$1.11$1.11
Q3 20251$1.15$1.15$1.15
Q4 20251$1.21$1.21$1.21
FY 20254$4.52$4.52$4.52
Q1 20261$1.19$1.19$1.19

AZN Earnings Date and Information

AstraZeneca last issued its earnings results on April 25th, 2024. The reported $1.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.95 by $0.08. The firm earned $12.68 billion during the quarter, compared to analysts' expectations of $11.92 billion. AstraZeneca has generated $2.04 earnings per share over the last year ($2.04 diluted earnings per share) and currently has a price-to-earnings ratio of 38.5. Earnings for AstraZeneca are expected to grow by 15.59% in the coming year, from $4.04 to $4.67 per share. AstraZeneca has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 26th, 2024 based off prior year's report dates.

Read More

AstraZeneca Earnings History by Quarter

Export to Excel

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
7/26/2024
(Estimated)
-------
4/25/2024Q1 2024$0.95$1.03+$0.08$1.36$11.92 billion$12.68 billion
2/8/2024Q4 2023$0.74$0.73($0.01)$1.15$12.07 billion$12.02 billion
11/8/2023Q3 2023$0.84$0.87+$0.03$1.30$11.55 billion$11.49 billion
7/28/2023Q2 2023$0.97$1.08+$0.11$1.57$11.06 billion$11.42 billion
4/27/2023Q1 2023$0.86$0.96+$0.10$1.34$10.80 billion$10.88 billion
2/9/2023Q4 2022$0.68$0.69+$0.01$1.09$11.40 billion$11.21 billion

AstraZeneca (AZN) Earnings Date and Reports 2024 (3)

Get the Latest News and Ratings for AZN and Related Stocks

Enter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter.

11/10/2022Q3 2022$0.77$0.84+$0.07$1.15$10.98 billion$10.98 billion
11/10/2022Q3 2022$0.77$0.84+$0.07$1.15$10.98 billion$10.98 billion
7/29/2022Q2 2022$0.78$0.86+$0.08$1.60$10.44 billion$10.77 billion
7/29/2022Q2 2022$0.78$0.86+$0.08$1.60$10.44 billion$10.77 billion
4/29/2022Q1 2022$0.86$0.95+$0.09$1.77$11.19 billion$11.39 billion
4/29/2022Q1 2022$0.86$0.95+$0.09$1.77$11.19 billion$11.39 billion
4/29/2022Q1 2022$0.86$0.95+$0.09$1.77$10.96 billion$11.39 billion
2/10/2022Q4 2021$0.77$0.84+$0.07$1.79$11.04 billion$12.01 billion
2/10/2022Q4 2021$0.77$0.84+$0.07$1.79$11.04 billion$12.01 billion
2/10/2022Q4 2021$0.77$0.84+$0.07$1.79$11.06 billion$11.50 billion
11/12/2021Q3 2021$0.63$0.54($0.09)$1.63$9.82 billion$9.87 billion
11/12/2021Q3 2021$0.63$0.54($0.09)$1.63$9.82 billion$9.87 billion
11/11/2021Q3 2021$0.62$0.54($0.08)$1.63$9.58 billion$9.74 billion
7/29/2021Q2 2021$0.45$0.45-$0.69$7.79 billion$8.22 billion
7/29/2021Q2 2021$0.45$0.45-$0.69$7.79 billion$8.22 billion
7/28/2021Q2 2021$0.43$0.45+$0.02$0.69$7.79 billion$8.22 billion
4/30/2021Q1 2021$0.71$0.81+$0.10$1.03$7.17 billion$7.32 billion
4/30/2021Q1 2021$0.71$0.81+$0.10$1.03$7.17 billion$7.32 billion
4/29/2021Q1 2021$0.71$0.82+$0.11$1.03$7.15 billion$7.32 billion
2/11/2021Q4 2020$0.53$0.54+$0.01$0.69$6.98 billion$7.41 billion
2/11/2021Q4 2020$0.53$0.54+$0.01$0.69$6.98 billion$7.41 billion
2/10/2021Q4 2020$0.68$0.54($0.14)$0.69$6.98 billion$7.41 billion
11/10/2020Q3 2020$0.44$0.47+$0.03$0.69$6.65 billion$6.58 billion
11/5/2020Q3 2020$0.49$0.47($0.02)$0.69$6.54 billion$6.58 billion
11/5/2020Q3 2020$0.49$0.47($0.02)$0.69$6.54 billion$6.58 billion
11/5/2020Q3 2020$0.49$0.47($0.02)$0.69$6.54 billion$6.58 billion
7/30/2020Q2 2020$0.44$0.48+$0.04$0.67$6.25 billion$6.28 billion
7/30/2020Q2 2020$0.44$0.48+$0.04$0.67$6.25 billion$6.28 billion
7/30/2020Q2 2020$0.44$0.48+$0.04$0.67$6.25 billion$6.28 billion
7/30/2020Q2 2020$0.44$0.48+$0.04$0.67$6.27 billion$6.28 billion
4/29/2020Q1 2020$0.47$0.53+$0.06$0.76$5.81 billion$6.35 billion
4/29/2020Q1 2020$0.47$0.53+$0.06$0.76$5.81 billion$6.35 billion
4/29/2020Q1 2020$0.47$0.53+$0.06$0.76$5.81 billion$6.35 billion
4/29/2020Q1 2020$0.47$0.53+$0.06$0.76$5.95 billion$6.35 billion
WARNING about the death of the U.S. dollar… (Ad)Where do you turn during times of economic uncertainty?Many elites trust storing their wealth in gold (which has historically boomed when the dollar’s value has plummeted!)Get Colonial Metals' new Precious Metals Investment Guide.
2/14/2020Q4 2019$0.53$0.45($0.08)$0.78$6.71 billion$6.66 billion
2/14/2020Q4 2019$0.53$0.45($0.08)$0.78$6.71 billion$6.66 billion
2/14/2020Q4 2019$0.53$0.45($0.08)$0.78$6.71 billion$6.66 billion
2/14/2020Q4 2019$0.53$0.45($0.08)$0.78$6.75 billion$6.66 billion
10/24/2019Q3 2019$0.45$0.50+$0.05$0.88$6.14 billion$6.41 billion
10/24/2019Q3 2019$0.45$0.50+$0.05$0.88$6.14 billion$6.41 billion
10/24/2019Q3 2019$0.45$0.50+$0.05$0.88$6.14 billion$6.41 billion
10/24/2019Q3 2019$0.45$0.50+$0.05$0.88$6.07 billion$6.13 billion
7/25/2019Q2 2019$0.32$0.37+$0.05$0.69$5.51 billion$5.82 billion
7/25/2019Q2 2019$0.32$0.37+$0.05$0.69$5.51 billion$5.82 billion
7/25/2019Q2 2019$0.32$0.37+$0.05$0.69$5.51 billion$5.82 billion
7/25/2019Q2 2019$0.30$0.73+$0.43$1.37$5.57 billion$5.72 billion

AstraZeneca Earnings - Frequently Asked Questions

When is AstraZeneca's earnings date?

AstraZeneca has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, July 26th, 2024 based off last year's report dates. Learn more on AZN's earnings history.

Did AstraZeneca beat their earnings estimates last quarter?

In the previous quarter, AstraZeneca (NASDAQ:AZN) reported $1.03 earnings per share (EPS) to beat the analysts' consensus estimate of $0.95 by $0.08. Learn more on analysts' earnings estimate vs. AZN's actual earnings.

How much revenue does AstraZeneca generate each year?

AstraZeneca (NASDAQ:AZN) has a recorded annual revenue of $45.81 billion.

How much profit does AstraZeneca generate each year?

AstraZeneca (NASDAQ:AZN) has a recorded net income of $5.96 billion. AZN has generated $2.04 earnings per share over the last four quarters.

What is AstraZeneca's price-to-earnings ratio?

AstraZeneca (NASDAQ:AZN) has a trailing price-to-earnings ratio of 38.50 and a forward price-to-earnings ratio of 19.44. The price/earnings-to-growth ratio is 1.41.

What is AstraZeneca's EPS forecast for next year?

AstraZeneca's earnings are expected to grow from $4.04 per share to $4.67 per share in the next year, which is a 15.59% increase.


More Earnings Resources from MarketBeat

Related Companies:

  • LLY Earnings Results
  • NVO Earnings Results
  • JNJ Earnings Results
  • MRK Earnings Results
  • ABBV Earnings Results
  • NVS Earnings Results
  • ABT Earnings Results
  • PFE Earnings Results
  • SNY Earnings Results
  • VRTX Earnings Results

Earnings Tools:

  • Today's Earnings
  • Tomorrow's Earnings
  • Next Week's Earnings
  • Upcoming Earnings Calls
  • Earnings Newsletter
  • Earnings Call Transcripts
  • Corporate Guidance
  • Earnings Screener

Earnings By Country:

  • U.S. Earnings Reports
  • Canadian Earnings Reports
  • U.K. Earnings Reports
  • Australia Earnings Reports

Latest Articles:

  • TD Bank Q2 Earnings: Record Highs and Regulatory Hurdles
  • PDD Holdings Earnings Volatility Alerts Buyers
  • Zoom Stock’s Earnings Volatility Picked Up a Lot of Buyers
  • Baidu Stock Earnings Prove Ray Dalio Right about China?
  • JD’s Earnings Could Mean Chinese Stocks Making a Comeback
  • Home Depot: Earnings Mixed, Wait to Buy the Dip
  • Traders Sell but Investors Still Win After Palantir's Earnings
AstraZeneca (AZN) Earnings Date and Reports 2024 (2024)
Top Articles
Latest Posts
Article information

Author: Zonia Mosciski DO

Last Updated:

Views: 5924

Rating: 4 / 5 (51 voted)

Reviews: 82% of readers found this page helpful

Author information

Name: Zonia Mosciski DO

Birthday: 1996-05-16

Address: Suite 228 919 Deana Ford, Lake Meridithberg, NE 60017-4257

Phone: +2613987384138

Job: Chief Retail Officer

Hobby: Tai chi, Dowsing, Poi, Letterboxing, Watching movies, Video gaming, Singing

Introduction: My name is Zonia Mosciski DO, I am a enchanting, joyous, lovely, successful, hilarious, tender, outstanding person who loves writing and wants to share my knowledge and understanding with you.